APA (7th ed.) Citation

M, M., C, G., M, V., A, R., D, L., N, M., . . . B, C. (2024). Modernizing the assessment and reporting of adverse events in oncology clinical trials using complementary statistical approaches: A case study of the MOTIVATE trial. Investigational new drugs, 42(6), 664. https://doi.org/10.1007/s10637-024-01481-9

Chicago Style (17th ed.) Citation

M, Morisseau, et al. "Modernizing the Assessment and Reporting of Adverse Events in Oncology Clinical Trials Using Complementary Statistical Approaches: A Case Study of the MOTIVATE Trial." Investigational New Drugs 42, no. 6 (2024): 664. https://doi.org/10.1007/s10637-024-01481-9.

MLA (9th ed.) Citation

M, Morisseau, et al. "Modernizing the Assessment and Reporting of Adverse Events in Oncology Clinical Trials Using Complementary Statistical Approaches: A Case Study of the MOTIVATE Trial." Investigational New Drugs, vol. 42, no. 6, 2024, p. 664, https://doi.org/10.1007/s10637-024-01481-9.